Literature DB >> 11535471

Drug use and five-year incidence of age-related cataracts: The Beaver Dam Eye Study.

B E Klein1, R Klein, K E Lee, L G Danforth.   

Abstract

OBJECTIVE: To evaluate incident cataract after a 5-year interval with respect to medication use.
DESIGN: Population-based incidence study. MAIN OUTCOME: Incident cataract judged from standard photographs.
SETTING: Study subjects were adults 43 to 86 years of age in 1988 to 1990 and again in 1993 to 1995. All participants were examined and interviewed, and photographs were taken. All procedures and grading were done by protocols at both examinations. All medications in current use, prescribed as well as over-the-counter, were brought to the examination site, and the names were recorded at that time.
RESULTS: There were 678 drug preparations (active ingredients) being used at the baseline examination. Significantly lower incidences of nuclear cataracts 5 years later occurred in those who took thiazide diuretics (odds ratio [OR] = 0.79, 95% confidence interval [CI] 0.63, 1.00) and aspirin (OR = 0.76, 95% CI 0.61, 0.95) at the baseline examination. There were significantly more incident cortical cataracts in those taking oral steroids (OR = 2.59, 95% CI 1.45, 4.62), amitriptyline (OR = 2.03, 95% CI 1.09, 3.79), oral hypoglycemic agents (OR 2.06, 95% CI 1.23, 3.44), and insulin (OR = 3.38, 95% CI 1.61, 7.08). There were significantly more incident posterior subcapsular cataracts in those taking potassium-sparing diuretics (OR = 2.13, 95% CI 1.42, 3.18) and oral hypoglycemic agents (OR = 2.89, 95% CI 1.57, 5.33). Considering past use with never and current use did not alter the patterns of associations. We were not able to separate the effects of antihypertensive or diuretic agents from that of hypertension. However, hypoglycemic agents were no longer associated with any cataract type after stratifying by diabetes status.
CONCLUSIONS: Although many different medications were being used at the baseline examination in the Beaver Dam Eye Study cohort, few were associated with incident cataract. However, with the high frequency of use of medications and the possibility that effects of current exposure may occur in the future, it is reasonable to follow this and other older cohorts for the development of cataract.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535471     DOI: 10.1016/s0161-6420(01)00656-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Associations of selected medications and visual function: the Beaver Dam Eye Study.

Authors:  B E K Klein; R Klein; M D Knudtson; K E Lee; L G Danforth; J O Reinke; A M Adler
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

2.  Glucocorticoids in the treatment of early and late RA.

Authors:  J W J Bijlsma; M Boers; K G Saag; D E Furst
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  Risk factors associated with incident cataracts and cataract surgery in the Age-related Eye Disease Study (AREDS): AREDS report number 32.

Authors:  Jessica R Chang; Euna Koo; Elvira Agrón; Joelle Hallak; Traci Clemons; Dimitri Azar; Robert D Sperduto; Frederick L Ferris; Emily Y Chew
Journal:  Ophthalmology       Date:  2011-11       Impact factor: 12.079

4.  Association of Single Nucleotide Polymorphisms in XRCC1 (194) and XPD (751) with Age-related cataract.

Authors:  Tafheem Khosa; Sana Aslam; Saima Mustafa; Atif Akbar; Rehan Sadiq Shaikh; Furhan Iqbal
Journal:  Int Ophthalmol       Date:  2017-05-30       Impact factor: 2.031

5.  Association between metabolic syndrome and age-related cataract.

Authors:  Sangshin Park; Eun-Hee Lee
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

6.  Cystatin C, other markers of kidney disease, and incidence of age-related cataract.

Authors:  Barbara E K Klein; Michael D Knudtson; Peter Brazy; Kristine E Lee; Ronald Klein
Journal:  Arch Ophthalmol       Date:  2008-12

7.  Cataract subtype risk factors identified from the Korea National Health and Nutrition Examination survey 2008-2010.

Authors:  Tyler Hyung Taek Rim; Min-Hyung Kim; Woon Cho Kim; Tae-Im Kim; Eung Kweon Kim
Journal:  BMC Ophthalmol       Date:  2014-01-10       Impact factor: 2.209

8.  Hypertension and risk of cataract: a meta-analysis.

Authors:  Xiaoning Yu; Danni Lyu; Xinran Dong; Jiliang He; Ke Yao
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

9.  Polymorphism of FABP2 and PPARG2 genes in risk prediction of cataract among North Indian population.

Authors:  Shania Abbas; Syed Tasleem Raza; Anu Chandra; Luxmi Singh; Saliha Rizvi; Ale Eba; Faisal Ahmed; Farzana Mahdi
Journal:  Meta Gene       Date:  2014-04-17

10.  Customized Clinical Practice Guidelines for Management of Adult Cataract in Iran.

Authors:  Zhaleh Rajavi; Mohammad Ali Javadi; Narsis Daftarian; Sare Safi; Farhad Nejat; Armin Shirvani; Hamid Ahmadieh; Saeid Shahraz; Hossein Ziaei; Hamidreza Moein; Behzad Fallahi Motlagh; Sepehr Feizi; Alireza Foroutan; Hassan Hashemi; Seyed Javad Hashemian; Mahmoud Jabbarvand; Mohammad Reza Jafarinasab; Farid Karimian; Hossein Mohammad-Rabei; Mehrdad Mohammadpour; Nader Nassiri; Mahmoodreza Panahi-Bazaz; Mohammad Reza Rohani; Mohammad Reza Sedaghat; Kourosh Sheibani
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.